Table I.
Participant Characteristics
| Parameter | Obese Participants | Control Participants | P Value |
|---|---|---|---|
| No. | 167 | 31 | |
| Age, y | 14±2.3 | 14.6±2.1 | NS |
| Sex, male/female | 92 (55%)/75 (45%) | 14 (45%)/17 (55%) | NS |
| Ethnic background, AA/CH | 45 (27%)/122 (73%) | 7 (23%)/24 (77%) | NS |
| BMI, kg/m2 | 38±7.5 | 20±2.8 | <.001 |
| BMI Z‐score | 2.47±0.36 | −0.08±0.87 | <.001 |
| Tanner stage, EP/LP | 47 (28%)/12 (72%) | 6 (19%)/25 (81%) | NS |
| Total cholesterol, mg/dL | 165±32 | 161±24 | NS |
| HDL‐C, mg/dL | 48±12 | 66±16 | <.001 |
| LDL‐C, mg/dL | 94±27 | 80±21 | NS |
| TG, mg/dL | 113±62 | 78±32 | <.001 |
| HbA1c, % | 5.5±0.4 | 5.4±0.3 | NS |
| HOMA | 6.4±5.6 | 2.1±1.2 | <.001 |
| IGT | 21/167 (12.6%) | 0/31 (0%) | .045 |
| Values are presented as mean ± SD. Abbreviations: AA, African American; BMI, body mass index; CH, Caribbean Hispanic; EP, early pubertal (T2–T3); HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; HOMA, homeostatic model assessment; IGT, impaired glucose tolerance; LDL‐C, low‐density lipoprotein cholesterol; LP, late pubertal (T4–T5); TG, triglyceride. | |||